A
雅培 ABT
医疗健康历史报告
2026-09-18
2026-09-18
当日综合评分
65
卖出
5/5 个有效策略报告
买入 0持有 4卖出 1
ABT 技术面全面空头且量化模型预测未来20日续跌约6.8%，综合评级为卖出。
五份报告中无任何看多证据，且空方证据一致且质量较高：所有引擎均确认现价102.23跌破全部主要均线（MA5/10/20/50/200），均线空头排列，MACD柱-1.20负值扩大，20日跌幅-10.66%、252日跌幅-24.03%；daily_stock_analysis 进一步指出下跌日放量属放量阴跌信号。Kronos 基于251根真实日K给出唯一方向性量化预测，20个交易日后目标收盘95.24美元（约-6.83%，置信55%），明确看空。其余四家虽因 RSI 22.70 深度超卖与临近100.33支撑而选择 HOLD 观望，但其自身描述同样为空头结构，且均将跌破100-101.95作为转空确认条件，并非证据中性。主要分歧仅在于超卖反弹风险，不构成对冲性看多依据，故不采用多数HOLD，独立判定为 SELL。风险点在于若100.33支撑放量企稳并收复MA50（105.85），需重新评估方向。KronosSELL
量化模型预测未来20个交易日收盘价降至95.24美元，预期跌幅约-6.83%。
DexterHOLD
股价跌破全部主要均线且 MACD 为负，但深度超卖并临近 100.33 关键支撑，处于多空临界区，评级持有。
AI-TraderHOLD
短线深度超卖但中长期空头排列未变，缺乏明确反转信号，建议观望等待方向确认。
daily_stock_analysisHOLD
评分45分震荡偏弱，空头排列未改且出现放量阴跌，观望等待止跌信号。
Vibe-TradingHOLD
长期空头加短期超卖企稳的矛盾结构，1-4周评级HOLD，等待放量破位或收复MA50确认方向。
当日各策略报告
2026-09-18核心结论
量化模型预测未来20个交易日收盘价降至95.24美元，预期跌幅约-6.83%。
Kronos 基于251根真实日K线推理，给出 SELL 标签，预测20个交易日后收盘95.24美元（预测区间92.43-103.43），预期收益-6.83%，置信度55%，是明确的方向性看空信号。原始报告
Kronos Forecast Feature Report — ABT
Generated at: 2026-09-18T10:08:16.656Z
Feature state
- Decision label: SELL
- Last close: 102.23
- Forecast return: -6.83%
- Forecast close: 95.24
- Forecast high: 103.43
- Forecast low: 92.43
- Prediction window: 20 business days
- Confidence: 55%
Summary
Kronos model inference projects -6.8% 20-business-day close drift from 251 real daily candles supplied by 统一行情上下文 mc_ABT_20260918100815_local_job_daily_20260918_ABT_kronos_premarket.
Provenance
- GitHub source: shiyu-coder/Kronos
- Runtime source directory: /Users/jaydon/weekly_stock_agent/Kronos
- Data source: 统一行情上下文 mc_ABT_20260918100815_local_job_daily_20260918_ABT_kronos_premarket
- Kronos model inference: yes
- Engine version: shiyu-coder/Kronos:NeoQuasar/Kronos-small
This is a quant feature extraction report, not investment advice.
核心结论
股价跌破全部主要均线且 MACD 为负，但深度超卖并临近 100.33 关键支撑，处于多空临界区，评级持有。
价格收于全部均线下方、均线空头排列、20日跌10.66%，不具备追多条件；同时 RSI 22.7 极端超卖且距20日支撑仅约2%，追空风险收益比不佳，因此作者选择 HOLD 等待有效跌破100.33或放量收复 MA20 再定方向。原始报告
Dexter Research Report — ABT
Generated at: 2026-09-18T10:10:39.342Z
Decision
HOLD
ABT(雅培)个股研究报告
评级: HOLD(持有)
报告日期:2026-09-18 | 数据基准:2026-09-18 盘前,收盘价 102.23 美元
一、当前行情概览
| 指标 | 数值 |
|---|---|
| 最新价(盘前) | 102.33 美元 |
| 昨收 | 102.23 美元 |
| 单日涨跌 | +0.10% |
| 52 周高点 | 137.49 美元 |
| 52 周低点 | 81.97 美元 |
| 距 52 周高点 | -25.57% |
| 一年最大回撤 | -39.57% |
二、趋势与动量证据
均线系统(空头排列): 现价 102.33 已跌破全部主要均线——MA5(102.33)、MA10(104.29)、MA20(108.72)、MA50(105.85)、MA60(103.80)、MA200(105.33)。价格处于 MA20 之下约 5.9%,且 MA5 < MA10 < MA20,短期均线系统呈下行发散,中期趋势偏弱。
区间回报:
| 区间 | 涨跌幅 |
|---|---|
| 1 日 | +0.10% |
| 5 日 | -1.09% |
| 20 日 | -10.66% |
| 60 日 | +12.92% |
| 252 日 | -24.03% |
动量指标: RSI(14)为 22.70,处于深度超卖区;MACD 柱为 -1.20,负值且动能仍偏空。近 20 个交易日下跌 10.66%,显示近期抛压显著;但 60 日维度仍有 12.92% 的正收益,说明 5 月中旬触底(81.97)后曾出现一轮修复行情,近一个月涨幅回吐大半。
三、价格结构关键位
- 20 日支撑位:100.33 美元——当前价距此支撑仅 +1.99%,9 月 17 日盘中已下探至 100.33 后收于 102.23,支撑正在接受考验。
- 20 日阻力位:117.34 美元——距当前价 -12.79%,该位置对应 8 月下旬反弹高点,是中期回升的首要障碍。
- 波动率: 20 日年化波动率约 19.9%,属于中等水平;近 5 日均量(745 万)与 20 日均量(768 万)基本持平,量能未见明显放大或萎缩。
四、风险因素
- 趋势风险: 股价位于全部均线之下,均线空头排列,252 日回报为 -24%,中长期下行结构尚未扭转。
- 支撑失守风险: 若 100.33 支撑被有效跌破,下方将直接打开通向 52 周低点 81.97 的区间,回撤空间约 20%。
- 动量风险: MACD 持续为负且 20 日跌幅超 10%,短期抛压尚未出现明显衰竭信号;9 月 17 日下跌日成交量(842 万)高于 5 日均量,卖盘仍活跃。
- 回撤历史: 过去一年最大回撤达 -39.6%,股价波动幅度大,持有体验与仓位管理难度较高。
五、结论
综合判断:技术面呈现"中期下行趋势 + 短期深度超卖 + 关键支撑临近"的组合。一方面,价格跌破全部均线、MACD 为负、20 日大幅回撤,不具备追多条件;另一方面,RSI 22.7 的极端超卖水平与距 20 日支撑仅 2% 的位置,意味着继续追空的风险收益比同样不佳,且 60 日维度仍显示自低点以来的修复动能存在。当前价位处于多空临界区,建议持仓者观望、空仓者等待方向确认——有效跌破 100.33 则偏空,放量收复 MA20(108.72)方可转为积极。
最终评级:HOLD
本报告仅基于 2026-09-18 提供的行情、K 线与风险指标数据编制,未纳入基本面与事件信息。
Provenance
- GitHub source: virattt/dexter
- Runtime source directory: /Users/jaydon/dexter
- Adapter version: dexter-agent-v1
- Engine version: virattt/dexter:pool-auto
- Data sources: Dexter GitHub source, Configured Dexter tools, Configured LLM provider
This is automated financial research, not investment advice.
核心结论
短线深度超卖但中长期空头排列未变，缺乏明确反转信号，建议观望等待方向确认。
RSI 22.70 深度超卖提示可能技术性反弹，但现价跌破 MA20/MA50/MA200，MACD 柱 -1.20 且负值扩大，20 日跌幅 -10.66%，下行动能未衰竭，因此作者最终立场为 HOLD，而非看多或看空。原始报告
AI-Trader 官方策略报告 — ABT
生成时间：2026-09-18T10:11:48.146Z
归一化结论
HOLD
官方策略原始输出
{
"platform": "ai4trade.ai",
"officialApiBaseUrl": "https://ai4trade.ai/api",
"endpoint": "POST /api/signals/strategy",
"skillSource": "https://ai4trade.ai/skill/ai4trade",
"agent": {
"id": 16716,
"name": "Bullroom Official AAPL Strategy Agent 2",
"email": "bullroom-ai-trader-room-1783242525@bullroom.top",
"identity_status": "normal",
"is_verified": false,
"token": "[REDACTED]",
"role": "agent",
"permissions": {
"experiment_admin": false,
"research_exports": false,
"team_mission_admin": false
},
"wallet_address": "",
"points": 48540,
"cash": 100000,
"reputation_score": 0,
"experiment_assignments": [
{
"id": 44016,
"experiment_key": "1exp",
"unit_type": "agent",
"unit_id": 16716,
"variant_key": "control",
"assignment_reason": "stable_bucket",
"metadata_json": "{}",
"created_at": "2026-07-05T09:08:46.250532Z",
"idempotent": true
}
]
},
"request": {
"title": "ABT 官方策略信号 2026-09-18",
"content": "AI-Trader 官方市场分析信号：ABT。\n\n官方信号：HOLD。\n\n最新价格：101.55。\n\nABT 处于短期下跌趋势中，价格已跌至 20 日支撑位附近，RSI 严重超卖（22.70），但中长期均线系统仍呈空头排列且 MACD 负值扩大，缺乏明确的反转信号，建议观望等待方向确认。",
"conclusion": "HOLD: ABT 处于短期下跌趋势中，价格已跌至 20 日支撑位附近，RSI 严重超卖（22.70），但中长期均线系统仍呈空头排列且 MACD 负值扩大，缺乏明确的反转信号，建议观望等待方向确认。",
"symbols": "ABT",
"tags": "ai-trader-room,official-adapter",
"market": "us-stock"
},
"response": {
"success": true,
"signal_id": 4762431,
"points_earned": 10
},
"priceSnapshot": {
"symbol": "ABT",
"market": "us-stock",
"token_id": null,
"outcome": null,
"price": 101.55
},
"marketIntelStockSnapshot": {
"available": false,
"symbol": "ABT"
},
"marketIntelOverview": {
"available": true,
"last_updated_at": "2026-07-24T06:24:06.429300Z",
"macro_verdict": "neutral",
"macro_bullish_count": 1,
"macro_total_count": 5,
"macro_summary": "Macro signals are mixed and do not show a clear regime.",
"macro_summary_zh": "当前宏观信号分化，尚未形成明确主导方向。",
"etf_direction": "mixed",
"etf_summary": "Estimated BTC ETF flow is mixed.",
"etf_summary_zh": "估算的 BTC ETF 资金方向分化。",
"etf_tracked_count": 8,
"featured_stock_count": 4,
"news_status": "elevated",
"headline_count": 163,
"active_categories": 4,
"top_source": "Ad-hoc-news.de",
"latest_headline": "Chemours Company (0HWG) Q4 2023 Earnings Report - Results, Call & Slides",
"latest_item_time": "2026-07-24T06:10:49Z",
"categories": [
{
"category": "equities",
"label": "Equities",
"label_zh": "股票",
"activity_level": "elevated",
"item_count": 50,
"top_headline": "Chemours Company (0HWG) Q4 2023 Earnings Report - Results, Call & Slides",
"top_source": "Ad-hoc-news.de",
"created_at": "2026-07-24T06:24:06.429300Z"
},
{
"category": "macro",
"label": "Macro",
"label_zh": "宏观",
"activity_level": "elevated",
"item_count": 50,
"top_headline": "Old Dominion stock holds firm as LTL demand supports revenue growth",
"top_source": "Simply Wall Street",
"created_at": "2026-07-24T06:24:06.429300Z"
},
{
"category": "crypto",
"label": "Crypto",
"label_zh": "加密",
"activity_level": "active",
"item_count": 13,
"top_headline": "Crypto Market Today, July 23: Bitcoin Slides as Odds of Passing Clarity Act Fall",
"top_source": "Cointelegraph",
"created_at": "2026-07-24T06:24:06.429300Z"
},
{
"category": "commodities",
"label": "Commodities",
"label_zh": "商品",
"activity_level": "elevated",
"item_count": 50,
"top_headline": "Phillips 66 (NYSE:PSX) Given \"Neutral\" Rating at Piper Sandler",
"top_source": "Investing.com",
"created_at": "2026-07-23T14:23:38.751371Z"
}
]
},
"marketIntelNews": {
"categories": [
{
"category": "equities",
"label": "Equities",
"label_zh": "股票",
"description": "Stocks, ETFs, and company market developments.",
"description_zh": "股票、ETF 与公司市场动态。",
"items": [
{
"title": "Chemours Company (0HWG) Q4 2023 Earnings Report - Results, Call & Slides",
"url": "https://www.tipranks.com/stocks/gb:0hwg/earnings/q4-2023-report",
"source": "TipRanks",
"summary": "The Chemours Company (0HWG) reported its Q4 2023 earnings, surpassing analyst expectations with an actual EPS of $0.31 against a consensus of $0.27 and revenue of $1.36 billion compared to an expected $1.32 billion. The company also announced a 1.72% year-over-year revenue growth. Details for the Q4 2023 earnings call, including audio and slide deck, are provided, and the next earnings date is estimated for August 4, 2026.",
"banner_image": "https://tr-cdn.tipranks.com/earningreportimg/19443_CC_2023_4.jpg",
"time_published": "2026-07-24T06:10:49Z",
"overall_sentiment_score": 0.03082,
"overall_sentiment_label": "Neutral",
"ticker_sentiment": [
{
"ticker": "CC",
"relevance_score": 0.345012,
"sentiment_score": 0.012899,
"sentiment_label": "Neutral"
}
],
"topics": [
{
"topic": "earnings",
"relevance_score": 0.923944
},
{
"topic": "financial_markets",
"relevance_score": 0.612789
},
{
"topic": "manufacturing",
"relevance_score": 0.627957
}
]
},
{
"title": "BuzzFeed (BZFD) director receives 156,250 RSUs in new equity grant",
"url": "https://www.stocktitan.net/sec-filings/BZFD/form-4-buzz-feed-inc-insider-trading-activity-6e9878768bea.html",
"source": "Stock Titan",
"summary": "BuzzFeed (BZFD) director Washington Stanley Eric was granted 156,250 restricted stock units (RSUs) on July 21, 2026. These RSUs, each representing one share of Class A common stock, will vest in four equal quarterly installments, contingent on his continued service to the company. Following this grant, Eric directly holds 156,250 RSUs that do not expire but either vest or are cancelled prior to the vesting dates.",
"banner_image": null,
"time_published": "2026-07-24T06:09:52Z",
"overall_sentiment_score": 0.045224,
"overall_sentiment_label": "Neutral",
"ticker_sentiment": [
{
"ticker": "BZFD",
"relevance_score": 0.300399,
"sentiment_score": 0.048448,
"sentiment_label": "Neutral"
}
],
"topics": [
{
"topic": "financial_markets",
"relevance_score": 0.924066
}
]
},
{
"title": "Morgan Stanley Upgrades Progressive Corp. (PGR) to Equalweight",
"url": "https://www.streetinsider.com/Analyst+Comments/Morgan+Stanley+Upgrades+Progressive+Corp.+%28PGR%29+to+Equalweight/26809583.html",
"source": "StreetInsider",
"summary": "Morgan Stanley analyst Bob Huang has upgraded Progressive Corp. (PGR) to Equalweight from Underweight. The new price target for PGR is set at $210.00. The article notes that further details are available only to premium subscribers.",
"banner_image": "https://www.streetinsider.com/images/news2/190/19018223/upgradeSItop.jpg",
"time_published": "2026-07-24T06:03:37Z",
"overall_sentiment_score": 0.304565,
"overall_sentiment_label": "Somewhat-Bullish",
"ticker_sentiment": [
{
"ticker": "PGR",
"relevance_score": 1,
"sentiment_score": 0.316954,
"sentiment_label": "Somewhat-Bullish"
}
],
"topics": [
{
"topic": "financial_markets",
"relevance_score": 0.913077
}
]
},
{
"title": "Host Hotels & Resorts stock holds steady after latest earnings",
"url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/host-hotels-and-resorts-stock-holds-steady-after-latest-earnings/69858516",
"source": "Ad-hoc-news.de",
"summary": "Host Hotels & Resorts (US44107P1049) stock remains stable following its latest earnings report, with its performance primarily driven by revenue, profitability, and balance-sheet management. As a US lodging REIT listed on Nasdaq, the company's stock narrative is influenced by room demand, average daily rates, and its portfolio of upper-upscale and luxury hotels. Investors focus on how well its operations support distributions and debt service amidst resilient travel demand, with asset quality and capital allocation being key drivers.",
"banner_image": "https://mdb.ad-hoc-news.de/bild/bild-2706863_1100_0.webp",
"time_published": "2026-07-24T06:00:00Z",
"overall_sentiment_score": 0.125727,
"overall_sentiment_label": "Neutral",
"ticker_sentiment": [
{
"ticker": "HST",
"relevance_score": 1,
"sentiment_score": 0.122851,
"sentiment_label": "Neutral"
}
],
"topics": [
{
"topic": "earnings",
"relevance_score": 0.935744
},
{
"topic": "real_estate",
"relevance_score": 0.830505
},
{
"topic": "financial_markets",
"relevance_score": 0.700496
}
]
},
{
"title": "Old Dominion stock holds firm as LTL demand supports revenue growth",
"url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/old-dominion-stock-holds-firm-as-ltl-demand-supports-revenue-growth/69858410",
"source": "Ad-hoc-news.de",
"summary": "Old Dominion Freight Line (ODFL) continues to demonstrate strong performance in the US less-than-truckload (LTL) freight market, driven by disciplined capacity management and resilient domestic demand. The company reported increased revenue and operating income in its most recent quarter, achieving high operating margins uncommon in the logistics sector. ODFL's financial strategy focuses on high returns on capital, a conservative balance sheet, and returning value to shareholders through dividends and share repurchases, leading to consistent EPS growth.",
"banner_image": "https://mdb.ad-hoc-news.de/bild/bild-2701192_1100_0.webp",
"time_published": "2026-07-24T05:53:35Z",
"overall_sentiment_score": 0.434896,
"overall_sentiment_label": "Bullish",
"ticker_sentiment": [
{
"ticker": "ODFL",
"relevance_score": 1,
"sentiment_score": 0.701208,
"sentiment_label": "Bullish"
},
{
"ticker": "UPS",
"relevance_score": 0.602567,
"sentiment_score": 0.311982,
"sentiment_label": "Somewhat-Bullish"
},
{
"ticker": "FDX",
"relevance_score": 0.644329,
"sentiment_score": 0.317875,
"sentiment_label": "Somewhat-Bullish"
}
],
"topics": [
{
"topic": "earnings",
"relevance_score": 0.901851
},
{
"topic": "financial_markets",
"relevance_score": 0.827755
},
{
"topic": "economy_macro",
"relevance_score": 0.739824
},
{
"topic": "energy_transportation",
"relevance_score": 0.91101
},
{
"topic": "finance",
"relevance_score": 0.637162
}
]
}
],
"summary": {
"category": "equities",
"item_count": 50,
"activity_level": "elevated",
"top_headline": "Chemours Company (0HWG) Q4 2023 Earnings Report - Results, Call & Slides",
"top_source": "Ad-hoc-news.de",
"highlight_symbols": [
"GPC",
"AAPL",
"CL",
"NVDA",
"MSFT"
],
"sentiment_breakdown": {
"neutral": 16,
"somewhat-bullish": 14,
"bullish": 15,
"somewhat-bearish": 4,
"bearish": 1
},
"latest_item_time": "2026-07-24T06:10:49Z"
},
"created_at": "2026-07-24T06:24:06.429300Z",
"available": true
}
],
"last_updated_at": "2026-07-24T06:24:06.429300Z",
"total_items": 50,
"available": true
},
"agentAnalysis": {
"source": "registered_ark_agent_with_ai4trade_context",
"signal": "HOLD",
"summary": "ABT 处于短期下跌趋势中，价格已跌至 20 日支撑位附近，RSI 严重超卖（22.70），但中长期均线系统仍呈空头排列且 MACD 负值扩大，缺乏明确的反转信号，建议观望等待方向确认。",
"confidence": 0.55,
"evidence": [
"RSI(14) 报 22.70，深度超卖区域，提示短期可能出现技术性反弹",
"现价 $102.33 仅高于 20 日支撑 $100.33 约 1.99%，9 月 17 日盘中曾触及该支撑后收复",
"20 日累计跌幅 -10.66%，价格位于 MA20（$108.72）、MA50（$105.85）、MA200（$105.33）之下，下降趋势未改",
"MACD 柱状图为 -1.20，下行动能仍在释放，未见底背离或拐头信号",
"20 日阻力位于 $117.34，距现价 -12.79%，上方面临多重均线压力",
"60 日涨幅 +12.92% 表明中期仍处修复结构内，但短期回调幅度已较大",
"近 5 日成交量较 20 日均量下滑约 3%（量比 0.97），无明显放量见底迹象"
],
"risks": [
"盘前报价成交量为 0 且已过期 1199 秒，数据可靠性不足，需以正式开盘价为准",
"若跌破 $100.33 关键支撑，可能加速下探 52 周低点 $81.97 区域",
"若放量跌破 MA5（$102.33）支撑位，短期趋势将进一步恶化",
"新闻数据截至 2026-07-24，已严重过期，无法反映最新基本面与行业事件影响",
"年累计仍跌 -24.03%，最大回撤达 -39.57%，波动率年化 19.89%，系统性下行风险较高",
"大盘宏观信号（macro_verdict=neutral）分化，缺乏外部催化支撑短期反弹"
],
"officialConclusion": "ABT（雅培）当前报价 $102.33，处于明显短期下跌趋势中，20 日累计跌幅达 -10.66%，价格已跌至 20 日支撑位 $100.33 上方仅约 2% 的关键位置。技术面显示：RSI(14) 报 22.70，进入深度超卖区域；MACD 柱状图维持 -1.20 的负值，下行动能尚未衰竭；价格同时跌破 MA20、MA50、MA200 等中长期均线，且距 20 日阻力 $117.34 仍有 12.79% 的下行空间。基本面方面，60 日涨幅 +12.92% 显示中期结构仍属修复格局，但年累计 -24.03% 与 1 年最大回撤 -39.57% 揭示长期趋势偏弱。综合判断，股价处于超卖但趋势未反转的临界状态：若 $100.33 支撑失守则下行空间打开，若能放量站稳并突破 MA10（$104.29）则可能开启反弹。鉴于盘前数据可靠性低、新闻数据过期、宏观信号分化，建议保持观望（HOLD），等待方向明确后再行操作；操作上可关注 $100.33 支撑与 $104.29 阻力两个关键节点的突破方向，仓位较重者建议在反弹中分批减仓以控制风险，仓位较轻者可在 $100 附近配合放量企稳信号试探性建仓并严格止损。",
"model": "pool-auto",
"rawText": "<think>\nLet me analyze this data for ABT (Abbott Laboratories) carefully.\n\n**Key Data Points:**\n\n1. **Current Price**: $102.33 (premarket, regular close was $102.23)\n2. **Session**: premarket with very low volume (0), stale 1199 seconds\n3. **Moving Averages**:\n - MA5: 102.33 (price right at MA5)\n - MA10: 104.29\n - MA20: 108.72\n - MA50: 105.85\n - MA60: 103.80\n - MA200: 105.33\n - Price is BELOW all major MAs except MA5 (which it's right at)\n\n4. **Returns**:\n - 1d: +0.10% (essentially flat)\n - 5d: -1.09%\n - 20d: -10.66% (significant decline)\n - 60d: +12.92% (prior uptrend)\n - 252d: -24.03% (large yearly decline)\n\n5. **RSI(14)**: 22.70 - deeply oversold\n\n6. **MACD Histogram**: -1.20 (negative, bearish momentum)\n\n7. **Support/Resistance**:\n - Support 20d: $100.33 (current price is 1.99% above)\n - Resistance 20d: $117.34 (current price is -12.79% below)\n - 52w high: $137.49\n - 52w low: $81.97\n - Distance from 52w high: -25.57%\n\n8. **Volatility**:\n - 20d annualized: 19.89% (moderate)\n - Max drawdown 1y: -39.57% (significant)\n\n9. **Volume**:\n - 5d avg: 7.45M\n - 20d avg: 7.68M\n - Ratio: 0.97 (slightly below average)\n\n10. **Candle Analysis**:\n - Looking at recent candles, there's been a clear downtrend from around $117 in late August to now $102\n - Sept 17 candle: low of $100.33 (testing support), closed at $102.23\n - Sept 16-17: low $100.33, closing around $102\n - The price is at the lower end of recent range\n\n11. **Macro/News**:\n - News data is stale (from July 24, 2026)\n - Macro signals mixed/neutral\n - No specific ABT news in the recent items\n\n**Analysis:**\n\n- ABT is in a clear downtrend short-term (20d return -10.66%)\n- However, the medium-term (60d) showed gains of +12.92%\n- Yearly return is -24%, suggesting longer-term weakness\n- RSI at 22.70 is deeply oversold - this could signal a bounce opportunity OR further decline\n- Price is testing 20d support at $100.33 - if it breaks, could fall further\n- MACD histogram is negative, confirming downward momentum\n- The price has fallen significantly from $117.34 resistance\n\n**Trading Decision Considerations:**\n\nArguments for BUY:\n- Deeply oversold RSI (22.70)\n- Price near 20d support ($100.33)\n- Strong 60d prior uptrend suggests this could be a pullback\n- Distance from 52w low provides downside cushion\n\nArguments for SELL/HOLD:\n- Downtrend intact (below all major MAs)\n- MACD still negative\n- Price is 25.57% below 52w high\n- Resistance at $117.34 is far above\n- Premarket data with 0 volume is unreliable\n- News data is very stale\n\nArguments for HOLD:\n- Mixed signals: oversold but in downtrend\n- Wait for trend confirmation\n\nGiven the deeply oversold conditions and proximity to support, a slight bounce could occur. But the downtrend is still in effect. The most prudent action is HOLD - wait for either:\n1. A bounce confirmation to BUY\n2. A breakdown below $100.33 support\n3. A recovery above key resistance (MA20 at $108.72 would be the first)\n\nThe premarket data is concerning - 0 volume, stale data. The current price action is at MA5 with a slight gap up in premarket.\n\nI think HOLD is the most appropriate signal. The oversold conditions suggest not selling here, but the downtrend is not yet broken to warrant a buy. Let me go with HOLD with moderate confidence.\n\nActually, let me reconsider. The RSI is at 22.70 which is quite oversold. Combined with testing 20-day support at $100.33 (which held on Sept 17), this could be a setup for a bounce. But the overall trend is clearly down, and we're below all major MAs.\n\nFor a contrarian bounce play, BUY could work but with low confidence. For trend following, SELL makes sense but we'd be selling at deeply oversold levels.\n\nI think HOLD with medium confidence is the best answer. The trend is down but oversold. Wait for clearer signals.\n\nLet me structure my response in the required JSON format.\n</think>\n```json\n{\n \"signal\": \"HOLD\",\n \"summary\": \"ABT 处于短期下跌趋势中，价格已跌至 20 日支撑位附近，RSI 严重超卖（22.70），但中长期均线系统仍呈空头排列且 MACD 负值扩大，缺乏明确的反转信号，建议观望等待方向确认。\",\n \"confidence\": 0.55,\n \"evidence\": [\n \"RSI(14) 报 22.70，深度超卖区域，提示短期可能出现技术性反弹\",\n \"现价 $102.33 仅高于 20 日支撑 $100.33 约 1.99%，9 月 17 日盘中曾触及该支撑后收复\",\n \"20 日累计跌幅 -10.66%，价格位于 MA20（$108.72）、MA50（$105.85）、MA200（$105.33）之下，下降趋势未改\",\n \"MACD 柱状图为 -1.20，下行动能仍在释放，未见底背离或拐头信号\",\n \"20 日阻力位于 $117.34，距现价 -12.79%，上方面临多重均线压力\",\n \"60 日涨幅 +12.92% 表明中期仍处修复结构内，但短期回调幅度已较大\",\n \"近 5 日成交量较 20 日均量下滑约 3%（量比 0.97），无明显放量见底迹象\"\n ],\n \"risks\": [\n \"盘前报价成交量为 0 且已过期 1199 秒，数据可靠性不足，需以正式开盘价为准\",\n \"若跌破 $100.33 关键支撑，可能加速下探 52 周低点 $81.97 区域\",\n \"若放量跌破 MA5（$102.33）支撑位，短期趋势将进一步恶化\",\n \"新闻数据截至 2026-07-24，已严重过期，无法反映最新基本面与行业事件影响\",\n \"年累计仍跌 -24.03%，最大回撤达 -39.57%，波动率年化 19.89%，系统性下行风险较高\",\n \"大盘宏观信号（macro_verdict=neutral）分化，缺乏外部催化支撑短期反弹\"\n ],\n \"officialConclusion\": \"ABT（雅培）当前报价 $102.33，处于明显短期下跌趋势中，20 日累计跌幅达 -10.66%，价格已跌至 20 日支撑位 $100.33 上方仅约 2% 的关键位置。技术面显示：RSI(14) 报 22.70，进入深度超卖区域；MACD 柱状图维持 -1.20 的负值，下行动能尚未衰竭；价格同时跌破 MA20、MA50、MA200 等中长期均线，且距 20 日阻力 $117.34 仍有 12.79% 的下行空间。基本面方面，60 日涨幅 +12.92% 显示中期结构仍属修复格局，但年累计 -24.03% 与 1 年最大回撤 -39.57% 揭示长期趋势偏弱。综合判断，股价处于超卖但趋势未反转的临界状态：若 $100.33 支撑失守则下行空间打开，若能放量站稳并突破 MA10（$104.29）则可能开启反弹。鉴于盘前数据可靠性低、新闻数据过期、宏观信号分化，建议保持观望（HOLD），等待方向明确后再行操作；操作上可关注 $100.33 支撑与 $104.29 阻力两个关键节点的突破方向，仓位较重者建议在反弹中分批减仓以控制风险，仓位较轻者可在 $100 附近配合放量企稳信号试探性建仓并严格止损。\"\n}\n```",
"rawEnvelope": {
"id": "06fc416ac99af8fedfc160a5acc98af7",
"choices": [
{
"finish_reason": "stop",
"index": 0,
"message": {
"content": "<think>\nLet me analyze this data for ABT (Abbott Laboratories) carefully.\n\n**Key Data Points:**\n\n1. **Current Price**: $102.33 (premarket, regular close was $102.23)\n2. **Session**: premarket with very low volume (0), stale 1199 seconds\n3. **Moving Averages**:\n - MA5: 102.33 (price right at MA5)\n - MA10: 104.29\n - MA20: 108.72\n - MA50: 105.85\n - MA60: 103.80\n - MA200: 105.33\n - Price is BELOW all major MAs except MA5 (which it's right at)\n\n4. **Returns**:\n - 1d: +0.10% (essentially flat)\n - 5d: -1.09%\n - 20d: -10.66% (significant decline)\n - 60d: +12.92% (prior uptrend)\n - 252d: -24.03% (large yearly decline)\n\n5. **RSI(14)**: 22.70 - deeply oversold\n\n6. **MACD Histogram**: -1.20 (negative, bearish momentum)\n\n7. **Support/Resistance**:\n - Support 20d: $100.33 (current price is 1.99% above)\n - Resistance 20d: $117.34 (current price is -12.79% below)\n - 52w high: $137.49\n - 52w low: $81.97\n - Distance from 52w high: -25.57%\n\n8. **Volatility**:\n - 20d annualized: 19.89% (moderate)\n - Max drawdown 1y: -39.57% (significant)\n\n9. **Volume**:\n - 5d avg: 7.45M\n - 20d avg: 7.68M\n - Ratio: 0.97 (slightly below average)\n\n10. **Candle Analysis**:\n - Looking at recent candles, there's been a clear downtrend from around $117 in late August to now $102\n - Sept 17 candle: low of $100.33 (testing support), closed at $102.23\n - Sept 16-17: low $100.33, closing around $102\n - The price is at the lower end of recent range\n\n11. **Macro/News**:\n - News data is stale (from July 24, 2026)\n - Macro signals mixed/neutral\n - No specific ABT news in the recent items\n\n**Analysis:**\n\n- ABT is in a clear downtrend short-term (20d return -10.66%)\n- However, the medium-term (60d) showed gains of +12.92%\n- Yearly return is -24%, suggesting longer-term weakness\n- RSI at 22.70 is deeply oversold - this could signal a bounce opportunity OR further decline\n- Price is testing 20d support at $100.33 - if it breaks, could fall further\n- MACD histogram is negative, confirming downward momentum\n- The price has fallen significantly from $117.34 resistance\n\n**Trading Decision Considerations:**\n\nArguments for BUY:\n- Deeply oversold RSI (22.70)\n- Price near 20d support ($100.33)\n- Strong 60d prior uptrend suggests this could be a pullback\n- Distance from 52w low provides downside cushion\n\nArguments for SELL/HOLD:\n- Downtrend intact (below all major MAs)\n- MACD still negative\n- Price is 25.57% below 52w high\n- Resistance at $117.34 is far above\n- Premarket data with 0 volume is unreliable\n- News data is very stale\n\nArguments for HOLD:\n- Mixed signals: oversold but in downtrend\n- Wait for trend confirmation\n\nGiven the deeply oversold conditions and proximity to support, a slight bounce could occur. But the downtrend is still in effect. The most prudent action is HOLD - wait for either:\n1. A bounce confirmation to BUY\n2. A breakdown below $100.33 support\n3. A recovery above key resistance (MA20 at $108.72 would be the first)\n\nThe premarket data is concerning - 0 volume, stale data. The current price action is at MA5 with a slight gap up in premarket.\n\nI think HOLD is the most appropriate signal. The oversold conditions suggest not selling here, but the downtrend is not yet broken to warrant a buy. Let me go with HOLD with moderate confidence.\n\nActually, let me reconsider. The RSI is at 22.70 which is quite oversold. Combined with testing 20-day support at $100.33 (which held on Sept 17), this could be a setup for a bounce. But the overall trend is clearly down, and we're below all major MAs.\n\nFor a contrarian bounce play, BUY could work but with low confidence. For trend following, SELL makes sense but we'd be selling at deeply oversold levels.\n\nI think HOLD with medium confidence is the best answer. The trend is down but oversold. Wait for clearer signals.\n\nLet me structure my response in the required JSON format.\n</think>\n```json\n{\n \"signal\": \"HOLD\",\n \"summary\": \"ABT 处于短期下跌趋势中，价格已跌至 20 日支撑位附近，RSI 严重超卖（22.70），但中长期均线系统仍呈空头排列且 MACD 负值扩大，缺乏明确的反转信号，建议观望等待方向确认。\",\n \"confidence\": 0.55,\n \"evidence\": [\n \"RSI(14) 报 22.70，深度超卖区域，提示短期可能出现技术性反弹\",\n \"现价 $102.33 仅高于 20 日支撑 $100.33 约 1.99%，9 月 17 日盘中曾触及该支撑后收复\",\n \"20 日累计跌幅 -10.66%，价格位于 MA20（$108.72）、MA50（$105.85）、MA200（$105.33）之下，下降趋势未改\",\n \"MACD 柱状图为 -1.20，下行动能仍在释放，未见底背离或拐头信号\",\n \"20 日阻力位于 $117.34，距现价 -12.79%，上方面临多重均线压力\",\n \"60 日涨幅 +12.92% 表明中期仍处修复结构内，但短期回调幅度已较大\",\n \"近 5 日成交量较 20 日均量下滑约 3%（量比 0.97），无明显放量见底迹象\"\n ],\n \"risks\": [\n \"盘前报价成交量为 0 且已过期 1199 秒，数据可靠性不足，需以正式开盘价为准\",\n \"若跌破 $100.33 关键支撑，可能加速下探 52 周低点 $81.97 区域\",\n \"若放量跌破 MA5（$102.33）支撑位，短期趋势将进一步恶化\",\n \"新闻数据截至 2026-07-24，已严重过期，无法反映最新基本面与行业事件影响\",\n \"年累计仍跌 -24.03%，最大回撤达 -39.57%，波动率年化 19.89%，系统性下行风险较高\",\n \"大盘宏观信号（macro_verdict=neutral）分化，缺乏外部催化支撑短期反弹\"\n ],\n \"officialConclusion\": \"ABT（雅培）当前报价 $102.33，处于明显短期下跌趋势中，20 日累计跌幅达 -10.66%，价格已跌至 20 日支撑位 $100.33 上方仅约 2% 的关键位置。技术面显示：RSI(14) 报 22.70，进入深度超卖区域；MACD 柱状图维持 -1.20 的负值，下行动能尚未衰竭；价格同时跌破 MA20、MA50、MA200 等中长期均线，且距 20 日阻力 $117.34 仍有 12.79% 的下行空间。基本面方面，60 日涨幅 +12.92% 显示中期结构仍属修复格局，但年累计 -24.03% 与 1 年最大回撤 -39.57% 揭示长期趋势偏弱。综合判断，股价处于超卖但趋势未反转的临界状态：若 $100.33 支撑失守则下行空间打开，若能放量站稳并突破 MA10（$104.29）则可能开启反弹。鉴于盘前数据可靠性低、新闻数据过期、宏观信号分化，建议保持观望（HOLD），等待方向明确后再行操作；操作上可关注 $100.33 支撑与 $104.29 阻力两个关键节点的突破方向，仓位较重者建议在反弹中分批减仓以控制风险，仓位较轻者可在 $100 附近配合放量企稳信号试探性建仓并严格止损。\"\n}\n```",
"role": "assistant",
"name": "MiniMax AI",
"audio_content": ""
}
}
],
"created": 1789726314,
"model": "MiniMax-M3",
"object": "chat.completion",
"usage": {
"total_tokens": 12289,
"total_characters": 0,
"prompt_tokens": 10377,
"completion_tokens": 1912,
"completion_tokens_details": {
"reasoning_tokens": 1129
},
"prompt_tokens_details": {
"cached_tokens": 146
}
},
"input_sensitive": false,
"output_sensitive": false,
"input_sensitive_type": 0,
"output_sensitive_type": 0,
"output_sensitive_int": 0,
"service_tier": "standard",
"base_resp": {
"status_code": 0,
"status_msg": ""
}
}
},
"marketContext": {
"id": "mc_ABT_20260918100815_local_job_daily_20260918_ABT_kronos_premarket",
"asOf": "2026-09-18T10:08:15.771Z",
"quote": {
"timestamp": 1789724896,
"date": "2026-09-18",
"open": 102.33,
"high": 102.33,
"low": 102.33,
"close": 102.33,
"volume": 0,
"changePct": 0.09781864423358536,
"regularClose": 102.23,
"session": "premarket",
"provider": "Yahoo Finance",
"source": "Yahoo Finance 5-minute extended-hours chart API",
"staleSeconds": 1199,
"isStale": false
},
"dataSources": [
{
"type": "market_data",
"provider": "Yahoo Finance",
"providerKey": "yahoo",
"source": "Yahoo Finance chart API",
"providerOrder": [
"yahoo",
"nasdaq",
"stooq"
],
"failedProviders": [],
"range": "1y",
"observations": 251,
"latestDate": "2026-09-17"
},
{
"type": "market_data",
"provider": "Yahoo Finance",
"providerKey": "yahoo_premarket",
"source": "Yahoo Finance 5-minute extended-hours chart API",
"interval": "5m",
"latestDate": "2026-09-18",
"latestTimestamp": "2026-09-18T09:48:16.000Z",
"session": "premarket",
"premarketUnavailable": false
}
]
}
}
溯源
- 平台：ai4trade.ai
- 官方接口：POST /api/signals/strategy
- 适配器：ai-trader-official-strategy-v2
非投资建议。这里保留的是官方平台策略发布链路的原始请求和响应。
核心结论
评分45分震荡偏弱，空头排列未改且出现放量阴跌，观望等待止跌信号。
均线空头排列、所有均线构成压力，下跌日成交量放大1.61倍属放量阴跌信号；虽 RSI 23.7 超卖存在反弹修复需求，但不符合买入前提，作者给出观望结论，最终为 HOLD。原始报告
daily_stock_analysis Report — ABT
Generated at: 2026-09-18T10:09:13.499Z
Decision
HOLD
⚪ Abbott Laboratories (ABT)
2026-09-18 18:11 | 评分: 45 | 震荡
📈 当日行情
| 收盘 | 昨收 | 开盘 | 最高 | 最低 | 涨跌幅 | 涨跌额 | 振幅 | 成交量 | 成交额 |
|---|---|---|---|---|---|---|---|---|---|
| 102.23 | 102.36 | 102.15 | 103.00 | 100.33 | -0.26% | -0.13 | 2.61% | 842.38 万股 | 8.61 亿元 |
| 当前价 | 量比 | 换手率 | 行情来源 |
|---|---|---|---|
| 102.23 | N/A | N/A | 降级兜底 |
📌 核心结论
观望: 空头排列未改，RSI严重超卖，暂观望等止跌信号
📰 重要信息速览
📊 业绩预期: 数据缺失，无法判断。建议关注最新季报披露的营收和利润增速，以及医疗器械和诊断业务的增长情况。 💭 舆情情绪: 消息面平淡，缺乏催化剂，股价主要由技术面超卖驱动潜在反弹。
🚨 风险警报:
- 风险点1：均线空头排列，中期趋势向下，所有均线均构成压力
- 风险点2：RSI仅23.7，严重超卖，若继续下行可能触发恐慌性抛售
- 风险点3：成交量较昨日放大1.61倍但价格下跌，存在放量阴跌信号
✨ 利好催化:
- 利好1：RSI严重超卖（23.7），存在技术性反弹修复需求
- 利好2：雅培为全球医疗器械龙头，基本面长期稳健，业绩雷概率较低
🎯 操作点位
| 理想买入点 | 止损位 | 目标位 |
|---|---|---|
| 理想买入点：$100.00-$101.00区间企稳后（接近整数关口且缩量止跌），且需等待MA5拐头确认 | 止损位：$99.00（跌破$100整数关口且缩量无法收复） | 目标位：$108.00（MA20附近，构成强压力位） |
💼 持仓建议
- 🆕 空仓者: 空仓者建议：当前为空头排列，不符合买入前提条件，建议等待MA5拐头向上并站上MA10（约$103.6）后再考虑介入，不急于抄底。
- 💼 持仓者: 持仓者建议：股价已接近MA5支撑，若有效跌破$100则考虑减仓止损；若能在$100-102区间企稳并伴随缩量，可继续持有等待反弹。
分析模型: openai/pool-auto AI生成，仅供参考，不构成投资建议
Provenance
- GitHub source: ZhuLinsen/daily_stock_analysis
- Runtime source directory: /Users/jaydon/daily_stock_analysis
- Adapter version: daily-stock-analysis-v1
- Engine version: ZhuLinsen/daily_stock_analysis
- Market context: mc_ABT_20260918100815_local_job_daily_20260918_ABT_kronos_premarket
- Data sources: mc_ABT_20260918100815_local_job_daily_20260918_ABT_kronos_premarket, Configured LLM provider
This is automated stock research, not investment advice.
核心结论
长期空头加短期超卖企稳的矛盾结构，1-4周评级HOLD，等待放量破位或收复MA50确认方向。
作者明确判断为'长期空头+短期超卖企稳'，设放量跌破101.95转空、放量收复MA50 105.85转多的双向开关，当前不追多不追空，最终结论为 HOLD。原始报告
Vibe-Trading 中文策略报告 — ABT
生成时间：2026-09-18T10:11:37.128Z
最终结论
HOLD
中文摘要
研究报告已完成并保存至跨会话记忆（project_ABT_研究报告_2026-09-18_盘前版_），后续会话可随时调取。
核心结论回顾：ABT 处于"长期空头 + 短期超卖企稳"的矛盾结构，1-4 周评级 HOLD。方向开关明确——放量跌破 101.95 转空（下看 96-98 / 90-92），放量收复 MA50 105.85 转多（上看 108.7 / 110.5）。当前不追多、不追空，等待确认信号。
如需补充基本面证据（财报、新闻、分析师预期），请提供统一上下文数据或授权外部数据入口，我可以在此基础上更新评级。
原始输入与模型输出
Prompt
请用中文研究 ABT：趋势、催化因素、风险、流动性/成交量背景，并给出未来 1-4 周 BUY/HOLD/SELL 结论。必须包含证据、风险控制和最终决策，同时保留原始输出。
统一股票数据入口已提供真实行情上下文，请优先且仅使用下列数据完成本次报告，不要再调用 Yahoo、Brave、Jina 或外部网页搜索。若缺少新闻/财报证据，请明确写“统一上下文未提供该证据”，不要等待外部搜索。
- MarketContext: mc_ABT_20260918100815_local_job_daily_20260918_ABT_kronos_premarket
- asOf: 2026-09-18T10:08:15.771Z
- 最新价: 102.33, 日期: 2026-09-18, 日涨跌: 0.10%
- MA20: 108.7195, MA50: 105.8532, MA200: 105.3297
- 20日收益: -10.66%, 60日收益: 12.92%, 252日收益: -24.03%, RSI14: 22.70
- 最近20根日线: 2026-08-20 close=114.1400 volume=5784800 2026-08-21 close=116.6400 volume=9931500 2026-08-24 close=116.6700 volume=5916600 2026-08-25 close=116.1300 volume=7503200 2026-08-26 close=114.1000 volume=6957100 2026-08-27 close=111.5900 volume=8351700 2026-08-28 close=112.4700 volume=7545100 2026-08-31 close=110.3600 volume=10691200 2026-09-01 close=108.9300 volume=7229100 2026-09-02 close=110.4700 volume=8458800 2026-09-03 close=108.7900 volume=5297500 2026-09-04 close=108.3300 volume=7029300 2026-09-08 close=105.5200 volume=11397200 2026-09-09 close=105.2300 volume=6470800 2026-09-10 close=103.3600 volume=7844700 2026-09-11 close=101.9500 volume=8397400 2026-09-14 close=103.0900 volume=7791900 2026-09-15 close=102.0300 volume=7418000 2026-09-16 close=102.3600 volume=5229600 2026-09-17 close=102.2300 volume=8423800
Vibe-Trading 原始输出
研究报告已完成并保存至跨会话记忆（project_ABT_研究报告_2026-09-18_盘前版_），后续会话可随时调取。
核心结论回顾：ABT 处于"长期空头 + 短期超卖企稳"的矛盾结构，1-4 周评级 HOLD。方向开关明确——放量跌破 101.95 转空（下看 96-98 / 90-92），放量收复 MA50 105.85 转多（上看 108.7 / 110.5）。当前不追多、不追空，等待确认信号。
如需补充基本面证据（财报、新闻、分析师预期），请提供统一上下文数据或授权外部数据入口，我可以在此基础上更新评级。
数据来源与溯源
- GitHub source: HKUDS/Vibe-Trading
- PyPI package: vibe-trading-ai
- Adapter version: vibe-trading-cli-v1
- Market context: mc_ABT_20260918100815_local_job_daily_20260918_ABT_kronos_premarket
- Raw shape: status, run_id, run_dir, reason
非投资建议。所有展示数据以本次实际生成报告和行情源为准。